{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T08:53:42Z","timestamp":1775724822921,"version":"3.50.1"},"reference-count":6,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2022,5,1]]},"DOI":"10.1001\/jamadermatol.2022.0241","type":"journal-article","created":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T20:04:30Z","timestamp":1648670670000},"page":"587","source":"Crossref","is-referenced-by-count":25,"title":["Treatment of Livedoid Vasculopathy With Baricitinib"],"prefix":"10.1001","volume":"158","author":[{"given":"Xiaoting","family":"Song","sequence":"first","affiliation":[{"name":"Department of Dermatology and Venereology, Peking University First Hospital, Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, National Clinical Research Center for Skin and Immune Diseases, NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Tu","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, Peking University First Hospital, Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, National Clinical Research Center for Skin and Immune Diseases, NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"2","key":"dlo220004r1","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1001\/jamadermatol.2017.4374","article-title":"Treatment for livedoid vasculopathy: a systematic review.","volume":"154","author":"Micieli","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"4","key":"dlo220004r2","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/ni.3691","article-title":"Mechanisms and consequences of Jak-STAT signaling in the immune system.","volume":"18","author":"Villarino","year":"2017","journal-title":"Nat Immunol"},{"issue":"4","key":"dlo220004r3","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.jaad.2016.12.004","article-title":"Janus kinase inhibitors in dermatology: A systematic review.","volume":"76","author":"Shreberk-Hassidim","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"dlo220004r4","doi-asserted-by":"publisher","DOI":"10.3390\/cells8080854","article-title":"Roles of JAK2 in aging, inflammation, hematopoiesis and malignant transformation.","volume":"8","author":"Perner","year":"2019","journal-title":"Cells"},{"issue":"1","key":"dlo220004r5","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1136\/annrheumdis-2016-210094","article-title":"Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study.","volume":"76","author":"Dougados","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"dlo220004r6","doi-asserted-by":"publisher","DOI":"10.1111\/dth.v33.6","article-title":"Refractory ulcerations associated with livedoid vasculopathy successfully treated with tofacitinib.","volume":"33","author":"Jia","year":"2020","journal-title":"Dermatol Ther"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2790345\/jamadermatology_song_2022_lo_220004_1652203172.76754.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T15:09:23Z","timestamp":1652886563000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2790345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,1]]},"references-count":6,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2022.0241","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,1]]}}}